Arcure (ALCUR.PA) down 10.06% to €2.77 at market close 16 Jan 2026: analyst focus

Arcure (ALCUR.PA) down 10.06% to €2.77 at market close 16 Jan 2026: analyst focus

ALCUR.PA stock led today’s top losers on EURONEXT, sliding 10.06% to €2.77 at market close on 16 Jan 2026. Trading volume hit 20,421 shares, roughly 2.88x the 50-day average. The move follows weak near-term momentum and mixed fundamentals that pushed the small-cap industrials name lower in Europe.

Price action and trading flow for ALCUR.PA stock

Arcure S.A. (ALCUR.PA) opened at €2.92 and printed a day low of €2.77 before settling at €2.77, down €0.31 from the prior close. Volume of 20,421 exceeded the average of 13,405, signaling heavier selling pressure. The stock’s 50-day average price is €2.84 and the 200-day average is €3.79, underlining a short-term weakness versus a longer-term base.

The intraday range, higher relative volume, and a close near session low indicate distribution. Traders should note the year high of €5.60 and year low of €2.34 when sizing risk.

Fundamentals and valuation: ALCUR.PA stock metrics

Arcure reports trailing EPS of -€0.12 and a negative P/E around -23.58, reflecting recent losses. Key ratios show Price/Book at 2.34 and Price/Sales at 1.11. The company has a current ratio of 2.81 and debt-to-equity of 1.15, indicating manageable short-term liquidity but material leverage for a small cap.

Revenue per share is €2.55 and free cash flow per share is -€0.22. These figures point to improving top-line scale but still negative profitability and cash conversion challenges in the near term.

Technical snapshot and trading signals for ALCUR.PA stock

Momentum indicators show a mixed picture. The RSI sits at 57.00, near neutral. MACD histogram is slightly positive with MACD -0.10 and signal -0.13, but ADX at 31.00 signals a strong trend, which today favored sellers. Bollinger Bands place the middle band at €2.64, with upper at €3.04 and lower at €2.24.

Short-term support sits near the year low €2.34 and resistance at the 50-day average €2.84. Traders watching mean-reversion trades should monitor volume and RSI moves below 45 for additional weakness.

Meyka AI rates and model forecast for ALCUR.PA stock

Meyka AI rates ALCUR.PA with a score of 65.80 out of 100 (Grade B — HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.

Meyka AI’s forecast model projects a monthly price of €2.50, a quarterly price of €2.15, and a yearly target of €1.10. Compared with the current €2.77, the yearly model implies a downside of about -60.26%. Forecasts are model-based projections and not guarantees.

Catalysts, risks and near-term outlook for ALCUR.PA stock

Near-term catalysts include contract wins for Blaxtair perimeter detection and updates on robot vision rollouts. Positive news could stabilise revenue growth and improve margins. Arcure’s FY earnings calendar shows the next earnings announcement on 18 Sep 2025, which could shift sentiment.

Primary risks are continued negative EPS, thin liquidity (shares outstanding 5,849,383), and high receivables days at 126.53. Sector pressure in Industrials and tighter capital markets for small caps may add selling risk. See the latest market compare data for context source and our company page for updates Meyka ALCUR.PA page.

Sector context and how ALCUR.PA stock compares

Arcure operates in Industrial – Machinery on EURONEXT with exposure to automation and safety sensors. The Industrials sector in Europe has returned 3.39% over six months, with average P/B near 2.44, close to Arcure’s 2.34. Sector peers with larger scale show stronger margins and liquidity, making Arcure a higher beta small-cap in the group.

Investors should weigh Arcure’s product traction against sector capital intensity. The company’s R&D-to-revenue ratio is 18.85%, which supports future product competitiveness but limits near-term free cash flow.

Final Thoughts

ALCUR.PA stock closed as one of today’s top losers on EURONEXT, down 10.06% to €2.77 on 16 Jan 2026, with volume at 20,421 shares. Fundamentals show improving revenue per share but persistent negative EPS (-€0.12) and constrained free cash flow. Technicals signal short-term weakness while the ADX suggests trend momentum. Meyka AI’s model projects a yearly figure of €1.10, implying a -60.26% downside versus today’s price, though shorter-term monthly and quarterly projections are nearer €2.50 and €2.15. The Meyka grade (Score 65.80/100, Grade B — HOLD) reflects mixed signals from sector peers, growth metrics and liquidity. Investors should treat this as a watch-list name and monitor contract news, cash flow updates and any shifts in receivables or leverage before reweighting positions. For real-time alerts and model updates use Meyka AI’s platform and the comparative market data source. Forecasts are model-based projections and not guarantees.

FAQs

Why did ALCUR.PA stock fall today?

The stock fell due to heavy intraday selling, higher volume (20,421), weak momentum and mixed fundamentals including negative EPS (-€0.12) and tight free cash flow. Sector pressure amplified the move.

What is Meyka AI’s rating for ALCUR.PA stock?

Meyka AI rates ALCUR.PA 65.80/100 (Grade B — HOLD). The grade combines benchmark and sector comparisons, growth, key metrics and analyst consensus. Not investment advice.

What price targets exist for ALCUR.PA stock?

Meyka AI’s model projects €2.50 monthly, €2.15 quarterly and €1.10 yearly. The yearly projection implies roughly -60.26% versus the current €2.77. Models are not guarantees.

How liquid is ALCUR.PA stock on EURONEXT?

Average daily volume is 13,405 shares; today’s volume was 20,421, about 2.88x average. Shares outstanding are 5,849,383, making it a thin small-cap with episodic liquidity.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *